epoprostenol
epoprostenol is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand names including Veletri, epoprostenol. Available dosage form: injection, powder, lyophilized, for solution.
Drug Details
- Generic Name
- epoprostenol
- Brand Names
- Veletri, epoprostenol
- Application Number
- NDA022260
- Sponsor
- Actelion Pharmaceuticals US, Inc.
- NDC Codes
- 4
- Dosage Forms
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- INTRAVENOUS
- Active Ingredients
- EPOPROSTENOL, EPOPROSTENOL SODIUM
Indications and Usage
1 INDICATIONS AND USAGE Epoprostenol for injection is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise capacity. Studies establishing effectiveness included predominantly patients with NYHA Functional Class III-IV symptoms and etiologies of idiopathic or heritable PAH or PAH associated with connective tissue diseases. Epoprostenol sodium is a prostanoid vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise capacity. Studies establishing effectiveness included predominantly patients with NYHA Functional Class III-IV symptoms and etiologies of idiopathic or heritable PAH or PAH associated with connective tissue diseases. (1)